Thermo Fisher Scientific to Present at the Baird 2018 Global Industrial Conference on November 7, 2018

Thermo Fisher Scientific to Present at the Baird 2018 Global Industrial Conference on November 7, 2018 WALTHAM, Mass., Oct. 29, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Dan Shine, senior vice president and president, Analytical Instruments, will present at the Baird 2018 Global Industrial Conference on... Read more

Thermo Fisher Scientific Completes Acquisition of Advanced Bioprocessing from BD

WALTHAM, Mass., Oct. 25, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today completed its previously announced acquisition of the Advanced Bioprocessing business from BD (Becton, Dickinson and Company – NYSE: BDX), a leading global medical technology company, for $477 million in cash, subject to post-closing adjustments. The... Read more

Passionate and Dedicated Employees Earn Agilent Recognition by Forbes as a World's Best Employer

Passionate and Dedicated Employees Earn Agilent Recognition by Forbes as a World’s Best Employer SANTA CLARA, Calif., October 25, 2018 Agilent Technologies Inc. (NYSE: A) today announced that it has been recognized by Forbes as one of the World’s Best Employers.  This marks the second consecutive year that Agilent has been named to this elite... Read more

MilliporeSigma Announces Agreement to Sell Amnis® Flow Cytometry and Guava® Technologies Businesses to Luminex Corporation

All associated reagents under these brands included in the deal Strategic agreement allows Luminex to increase footprint in multi-billion-dollar flow cytometry market Deal expected to close at end of 2018 Burlington, Massachusetts, October 18, 2018 — MilliporeSigma today announced the signing of a definitive agreement to sell its Flow Cytometry unit to Luminex Corporation for $75... Read more

Thermo Fisher Scientific CE Marks Oncomine Dx Target Test

CARLSBAD, Calif., Oct. 17, 2018 /PRNewswire/ — Marking a milestone in bringing its Oncomine Dx Target Test to Europe, Thermo Fisher Scientific today announced that it has CE-IVD marked its next-generation sequencing (NGS)-based solution that screens biomarkers across solid tumors. Thermo Fisher will highlight the test during the European Society for Medical Oncology (ESMO) Congress... Read more

Quantum Analytics Enters into Distribution Agreement with Bruker AXS for Benchtop XRF and XRD Products in the United States

New Distribution Agreement with Bruker AXS October 16, 2018 – Foster City, California – Quantum Analytics is excited to announce that it has entered into a distribution agreement with Bruker AXS, a global market leader in advanced X-ray solutions for materials research and quality control in applied, pharmaceutical, and industrial applications. Under this new agreement, customers... Read more

Merck KGaA, Darmstadt, Germany, Aims to Return to Profitable Growth as of 2019

Merck KGaA, Darmstadt, Germany, expects strong growth impetus starting next year, as the company reported today to analysts and investors at its Capital Markets Day. 16 OCT 2018 | DARMSTADT, GERMANY Pharmaceutical pipeline to unfold full potential Life Science continues to aim for above-market profitable growth Performance Materials focusing on the electronics industry and realigns R&D Merck... Read more

Shimadzu has released the Micro Volume QuEChERS Kit for LC/MS (Forensic).

October 16, 2018 Micro Volume QuEChERS Kit for LC/MS (Forensic) Biological Sample Pretreatment Kit This pretreatment kit for human biological samples is intended for the field of forensic medicine. Salt precipitation via QuEChERS extraction salts is adopted as the method* for extracting toxicants in blood and urine. The sample volume has been scaled down to... Read more

Thermo Fisher Scientific Custom Microarrays Drive Large-Scale Genotyping Study of Finnish Population

Thermo Fisher Scientific Custom Microarrays Drive Large-Scale Genotyping Study of Finnish Population FinnGen, a first-of-its-kind study of 500,000 individuals, combines genomics and health record data to better understand disease origins and improve human health SANTA CLARA, Calif., Oct. 16, 2018 /PRNewswire/ — Thermo Fisher Scientific today announced facilitation of the next phase of the FinnGen precision... Read more